REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector. Weiterlesen
It was fast compared to the other companies. In retrospect, speed could be because of turnover.
Was sind einige der besten Dinge an Ihrem Team?
In isolation team members care for you, on a 1-on-1 basis. Managers and executives are not so caring.
Other Employee Reviews for REGENXBIO
×